{"id":"W2038934354","doi":"10.3747/co.19.1114","title":"Treatment Paradigms for Patients with Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line","year":2012,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pemetrexed; Erlotinib; Oncology; Internal medicine; Lung cancer; Crizotinib; Carboplatin; Docetaxel; Chemotherapy; Bevacizumab; Gefitinib; Cetuximab; Cancer; Epidermal growth factor receptor; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004346139,0.0002044108,0.0003963126,0.00006653365,0.000119856,0.000008509975,0.00003385671,0.00004725426,0.0001175361],"category_scores_gemma":[0.000008004771,0.00013155,0.00006136188,0.00007251296,0.00005152166,0.00007814993,0.00001535366,0.00007017492,0.000006018128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005982598,"about_ca_system_score_gemma":0.0002776249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005159002,"about_ca_topic_score_gemma":0.0002036455,"domain_scores_codex":[0.9990965,0.00001935899,0.0002018628,0.0002355728,0.00008246587,0.0003642564],"domain_scores_gemma":[0.9992586,0.0001281615,0.0001235025,0.0001545272,0.00009553261,0.0002396347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005180786,0.00531831,0.9277005,0.0006646916,0.0007549351,0.000005140719,0.003642833,0.00001086523,0.00001145179,0.0001362583,0.003016631,0.05822037],"study_design_scores_gemma":[0.03924244,0.009170087,0.1864585,0.0001711566,0.006170656,0.00002607084,0.0002838571,0.0009040778,0.0003090816,0.00002873668,0.7568721,0.000363209],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826937,0.01122389,0.0005407442,0.0005818559,0.0008985004,0.002551775,0.0002926752,0.00002953684,0.001187311],"genre_scores_gemma":[0.9935151,0.0009530673,0.001980534,0.0001238181,0.0002676863,0.001806306,0.0004515231,0.00003174876,0.0008702104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7538555,"threshold_uncertainty_score":0.5364453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05009744908512064,"score_gpt":0.3993068974870531,"score_spread":0.3492094484019325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}